GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mycenax Biotech Inc (ROCO:4726) » Definitions » Market Cap

Mycenax Biotech (ROCO:4726) Market Cap : NT$7,777.5 Mil (As of Apr. 07, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Mycenax Biotech Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Mycenax Biotech's share price for the quarter that ended in Dec. 2024 was NT$43.4. Mycenax Biotech's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 207.0 Mil. Therefore, Mycenax Biotech's market cap for the quarter that ended in Dec. 2024 was NT$8,984.1 Mil.

Mycenax Biotech's quarterly market cap declined from Jun. 2024 (NT$12,143.2 Mil) to Sep. 2024 (NT$10,248.1 Mil) and declined from Sep. 2024 (NT$10,248.1 Mil) to Dec. 2024 (NT$8,984.1 Mil).

Mycenax Biotech's annual market cap declined from Dec. 2022 (NT$7,699.0 Mil) to Dec. 2023 (NT$7,343.0 Mil) but then increased from Dec. 2023 (NT$7,343.0 Mil) to Dec. 2024 (NT$8,984.1 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Mycenax Biotech's Enterprise Value for Today is NT$8,382.8 Mil.


Mycenax Biotech Market Cap Historical Data

The historical data trend for Mycenax Biotech's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mycenax Biotech Market Cap Chart

Mycenax Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,129.26 5,811.36 7,698.98 7,342.99 8,984.10

Mycenax Biotech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,342.99 7,925.19 12,143.20 10,248.10 8,984.10

Competitive Comparison of Mycenax Biotech's Market Cap

For the Biotechnology subindustry, Mycenax Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mycenax Biotech's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mycenax Biotech's Market Cap distribution charts can be found below:

* The bar in red indicates where Mycenax Biotech's Market Cap falls into.


;
;

Mycenax Biotech Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Mycenax Biotech's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=NT$43.4*207.007
=NT$8,984.1

Mycenax Biotech's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=NT$43.4*207.007
=NT$8,984.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mycenax Biotech  (ROCO:4726) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Mycenax Biotech Market Cap Related Terms

Thank you for viewing the detailed overview of Mycenax Biotech's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Mycenax Biotech Business Description

Traded in Other Exchanges
N/A
Address
No.66, Shengyi 2nd Road, 7th Floor, Hsinchu Science Park, Hsinchu County, Zhubei, TWN, 302041
Mycenax Biotech Inc is a Taiwan-based biopharmaceutical company. It is engaged in the development and manufacture of biopharmaceutical products, specializing in mammalian and microbial cell-derived biologics. The company provides services for program evaluation/confirmation, cell line development, and construction, process development technology platforms, drug characterization analysis, the establishment of testing methods, and drug production in accordance with PIC/S GMP manufacturing standards.

Mycenax Biotech Headlines

No Headlines